The Drug used to treat Ted Kennedy’s Brain Cancer Temozolomide (Temodal™) was developed at Aston University in Britain..
http://www.medscape.com/viewarticle/708105
http://en.wikipedia.org/wiki/Temozolomide
The Drug used to treat Ted Kennedy’s Brain Cancer Temozolomide (Temodal™) was developed at Aston University in Britain..
http://www.medscape.com/viewarticle/708105
http://en.wikipedia.org/wiki/Temozolomide
The MRI and CAT Scans used to diagnose and help treat Senator Kennedy’s Brain Cancer were developed with British expertise.
Sir Peter Mansfield - Noble Prize for his role in developing Magnetic Resonance Imaging (MRI).
http://en.wikipedia.org/wiki/Peter_Mansfield
Sir Godfrey Newbold Hounsfield who was awarded a Nobel Prize for his part in the development of X-ray computed tomography (CT). His name is immortalised in the Hounsfield scale, a quantitative measure of radiodensity used in evaluating CT scans. The use of such CT scanning allows radiologists to determine the exact size and shape of tumours and has led to the development of further radiotherapy techniques.
http://en.wikipedia.org/wiki/Godfrey_Hounsfield
London’s Royal Marsden Hospital and its academic partner, The Institute of Cancer Research have discovered or developed more new anti-cancer drugs than the National Cancer Institute in the USA.
http://www.royalmarsden.nhs.uk/RMH/privatecare/privatecare/worldleadingexpertise.htm
Harpal Kumar, chief executive of Cancer Research UK, said: “Years of research are behind the dramatic progress being made in the fight against Britain’s common cancers. Survival rates have doubled in the last thirty years and the work of Cancer Research UK has been at the heart of that progress.
“Our research is behind 19 of the top 20 drugs used to treat cancer patients worldwide today. Our work has underpinned the huge progress we are now seeing in preventing more deaths from lung cancer. And our progress over decades has helped to develop radiotherapy as a major form of treatment for half of all cancer patients.
http://www.telegraph.co.uk/health/healthnews/5785681/Deaths-from-common-cancers-at-40-year-low.html
Whilst just the other day it was announced that researchers at Imperial College London had managed to halt the growth of cancerous tumours, in what could be an important step towards the eventual eradication of this terrible illness.
http://www.dailymail.co.uk/health/article-1208840/Scientists-close-breast-cancer-cure-British-researchers-way-stop-tumours-growing.html
It should also be noted that Britain has a thriving Pharma and Bio-Techs Industry, with British Companies such as Glaxo Smith Kline (GSK) and Astra Zeneca being amongst the top pharmaceutical companies in the world, whilst Pfizer and other such companies have major research facilities in the UK.
http://www.dh.gov.uk/en/Healthcare/Medicinespharmacyandindustry/Industrybranch/DH_4000038
In terms of UK Cancer treatment the vast majority of NHS patients with suspected cancer (94.5%) see a specialist within two weeks and 98.2% of NHS patients diagnosed with cancer receive their first treatment within one month, however these targets are now set to be mandatory and any patient not seen within the 2 week period will be entitled to a private consultation payed for by the NHS.
http://www.telegraph.co.uk/health/healthnews/5663791/Patients-to-be-given-new-right-to-see-cancer-specialist-within-two-weeks.html
http://www.telegraph.co.uk/health/healthnews/5785681/Deaths-from-common-cancers-at-40-year-low.html
http://info.cancerresearchuk.org/news/archive/pressreleases/2009/july/drop-in-deaths-common-cancers
http://www.hi-mag.com/healthinsurance/article.do?articleid=20000152001
Professor Darzi, Chair of surgery at Imperial College London has recently written an article in the Washington Post in defence of Britain’s National Health Service.
http://www.washingtonpost.com/wp-dyn/content/story/2009/08/16/ST2009081602108.html
Cancer Research UK have recently responded to the figures regarding US/UK Cancer Statistics being quoted by some less credible media souces and you can read their response here -
http://scienceblog.cancerresearchuk.org/2009/08/17/we-need-to-be-careful-when-comparing-us-and-uk-cancer-care/
http://info.cancerresearchuk.org/news/behindtheheadlines/europeancancersurvival/
http://www.independent.co.uk/news/cancer-deaths-in-britain-no-worse-than-elsewhere-1124751.html
Professor Darzi, Chair of surgery at Imperial College London has recently written an article in the Washington Post in defence of Britain’s National Health Service.
http://www.washingtonpost.com/wp-dyn/content/story/2009/08/16/ST2009081602108.html
Cancer Research UK have recently responded to the figures regarding US/UK Cancer Statistics being quoted by some less credible media souces and you can read their response here -
http://scienceblog.cancerresearchuk.org/2009/08/17/we-need-to-be-careful-when-comparing-us-and-uk-cancer-care/
http://info.cancerresearchuk.org/news/behindtheheadlines/europeancancersurvival/
http://www.independent.co.uk/news/cancer-deaths-in-britain-no-worse-than-elsewhere-1124751.html
So much for Republican claims regarding British Medical Innovation and
suggestions that people like Stephen Hawkings would have died in Britain.
The truth being Ted Kennedy relied on British Medical Innovation developed alongside British NHS Hospitals in order to extend his life.
Sorry for posting some of the above twice - a few technical problems.
Thanks for posting some rational stuff about healthcare in the UK. There’s been so much disinformation about a system that the British public overwhelmingly supports. Even the conservatives there have asserted their support of it.
Brits live longer than Americans and spend much less on healthcare. If that’s socialism, give me a piece.
powered by Yahoo Answers